PRCT - NASDAQ
PROCEPT BioRobotics Corporation
$26.84
+0.31%PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. As of December 31, 2021, it had an install base of 130 AquaBeam Robotic Systems worldwide comprising 78 in the United States. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in Redwood City, California.
At a Glance
Live Snapshotprct
Total Stockholders' Equity
Last Annual Value
365.87M
3-Year CAGR
23%
5-Year CAGR
43%
10-Year CAGR
16%
PROCEPT BioRobotics Corporation Competitors Analysis of Total Stockholders' Equity
| Company | Total Stockholders' Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
PROCEPT BioRobotics Corporation NASDAQ:PRCT | 365.87M | 9.2% | 6.5% | N/A | |
 SS Innovations International, Inc. NASDAQ:SSII | 38.22M | 38.8% | 206.5% | N/A | |
 Guardian Pharmacy Services, Inc. NYSE:GRDN | 205.76M | 93.9% | 53.8% | N/A | |
 QuidelOrtho Corporation NASDAQ:QDEL | 1.92B | -27.3% | -0.1% | 25.3% | |
 Twist Bioscience Corporation NASDAQ:TWST | 472.96M | -8.8% | -4.0% | N/A | |
 Edgewise Therapeutics, Inc. NASDAQ:EWTX | 522.26M | 17.9% | 13.7% | N/A | |
 Artivion, Inc. NYSE:AORT | 448.23M | 16.7% | 8.3% | 7.9% | |
 Clover Health Investments, Corp. NASDAQ:CLOV | 308.70M | 2.5% | -10.4% | N/A | |
 Inspire Medical Systems, Inc. NYSE:INSP | 781.16M | 10.9% | 27.8% | N/A |
PROCEPT BioRobotics Corporation Fair Value Envelope
Related Guides
Continue your PRCT research with focused valuation guides.
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.